Compugen Ltd
NASDAQ:CGEN

Watchlist Manager
Compugen Ltd Logo
Compugen Ltd
NASDAQ:CGEN
Watchlist
Price: 1.5 USD 2.04% Market Closed
Market Cap: 140.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

CGEN Price Targets Summary
Compugen Ltd

Wall Street analysts forecast CGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGEN is 6.12 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

CGEN Lowest Forecast
Wall Street Target
4.04 USD
169% Upside
CGEN Average Forecast
Wall Street Target
6.12 USD
308% Upside
CGEN Highest Forecast
Wall Street Target
10.5 USD
600% Upside
Lowest
Price Target
4.04 USD
169% Upside
Average
Price Target
6.12 USD
308% Upside
Highest
Price Target
10.5 USD
600% Upside
Compugen Ltd Competitors:
Price Targets
CHEMM
Chemometec A/S
21% Upside
MCAP
MedCap AB (publ)
30% Upside
PIQ
Proteomics International Laboratories Ltd
10% Upside
603259
WuXi AppTec Co Ltd
34% Upside
CHEMM
Chemometec A/S
21% Upside
MCAP
MedCap AB (publ)
30% Upside
PIQ
Proteomics International Laboratories Ltd
10% Upside
603259
WuXi AppTec Co Ltd
34% Upside
O
OABI
OmniAb Inc
482% Upside
T
TEM
Tempus AI Inc
8% Upside
ADPT
Adaptive Biotechnologies Corp
17% Upside
TMO
Thermo Fisher Scientific Inc
44% Upside

Revenue
Forecast

Revenue Estimate
Compugen Ltd

For the last 8 years the compound annual growth rate for Compugen Ltd's revenue is 58%. The projected CAGR for the next 3 years is 20%.

58%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Compugen Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Compugen Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

See Also

Summary
CGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
CGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CGEN stock valuation using valuation multiples.
Wall Street Estimates
CGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CGEN's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CGEN is 6.12 USD with a low forecast of 4.04 USD and a high forecast of 10.5 USD.

What is Compugen Ltd's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Compugen Ltd's revenue is 58%. The projected CAGR for the next 3 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.